Development of the First Batch of National Reference Material and the Control Material for Hemocoagulase Bothrops Atrox

Liu Lisha, Deng Lijuan, Ren Xue, Fan Huihong

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (12) : 1456-1463.

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (12) : 1456-1463. DOI: 10.16153/j.1002-7777.2019.12.020
Drug Research

Development of the First Batch of National Reference Material and the Control Material for Hemocoagulase Bothrops Atrox

  • Liu Lisha, Deng Lijuan, Ren Xue, Fan Huihong
Author information +
History +

Abstract

Objective: To establish the first batch of national reference material and the control material for hemocoagulase bothrops atrox. Methods: The physicochemical analysis, titer determination and stability testing of the reference material for hemocoagulase bothrops atrox were carried out. The structural identification, purity testing, physicochemical analysis and stability testing of the control for hemocoagulase bothrops atrox were carried out. Results: The titer of the hemocoagulase bothrops atrox used for titer determination was 101 units per ampoule. The control material with accurate structure and high purity was established for identification and testing. Conclusion: The establishment of the first batch of the reference material and the control material for hemocoagulase bothrops atrox can be applied to the quality control of drugs and lay a basis for the quality research on enzyme biochemical drugs.

Key words

hemocoagulase bothrops atrox;reference material;control material;first batch;quality analysis

Cite this article

Download Citations
Liu Lisha, Deng Lijuan, Ren Xue, Fan Huihong. Development of the First Batch of National Reference Material and the Control Material for Hemocoagulase Bothrops Atrox[J]. Chinese Pharmaceutical Affairs, 2019, 33(12): 1456-1463 https://doi.org/10.16153/j.1002-7777.2019.12.020

References

[1] 郑颖,沈居仁,范泉水. 蛇毒血凝酶的比较[J]. 蛇志, 2008,20(3):218-219.
[2] 郝云飞,刘国辉,康强军. 注射用矛头蝮蛇血凝酶应用于腰椎退行性疾病手术中的有效性及安全性[J]. 临床合理用药,2018,11(2A):48-52.
[3] 许海艳,杨见明. 矛头蝮蛇血凝酶不同用法对功能性鼻内镜手术止血效果的影响[J]. 中医药临床杂志, 2017,29(12):2113-2115.
[4] 王兆钺. 注射用血凝酶体内外止血作用的研究[J]. 中国医院用药评价与分析,2012,12(6):486-487.
[5] 曹金铎. 注射用血凝酶临床应用的国内文献综述[J]. 中国医院用药评价与分析,2012,12(6):485-486.
[6] Castro HC, Zingali RB, Albuquerque MG, et al. Snake Venom Thrombin-like Enzymes:from Reptilase to Now[J]. Cellular and Molecular Life Sciences,2004,61:843-856.
[7] Yau Sang Chan, Randy Chi Fai Cheung, Lixin Xia, et al. Snake Venom Toxins:Toxicity and Medicinal Applications[J]. Appl Microbiol Biotechnol,2016,100:6165-6181.
[8] 孙东,石皎,丁忠福,等. 一种新的蛇毒凝血酶原激活物的分离纯化及特征[J]. 中国生物化学与分子生物学报,2011,27(12):1141-1148.
[9] 李秀琳,孙东,丁忠福,等. 矛头蝮蛇血凝酶工作标准品的协作标定[J]. 中国药品标准,2016,17(2):123-127.
[10] 中国药典:四部[S]. 2015:附录69-70、96-97、378-379.

27

Accesses

0

Citation

Detail

Sections
Recommended

/